| Miss Stephanie Pulikkottil Joseph, MD | |
|
707 E Main St, Middletown, NY 10940-2650 | |
| (845) 333-7575 | |
| Not Available |
| Full Name | Miss Stephanie Pulikkottil Joseph |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 707 E Main St, Middletown, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548558133 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | A137779 (California) | Secondary |
| 208100000X | Physical Medicine & Rehabilitation | 307576 (New York) | Primary |
| Entity Name | Hudson Vista Medical Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659666840 PECOS PAC ID: 8628240215 Enrollment ID: O20111003000643 |
News Archive
SpectraScience, Inc. (OTC Bulletin Board: SCIE), a San Diego based medical device company, today announced that its application for premarket approval (PMA) relating to key enhancements of its WavSTAT platform technology has been approved by the Food and Drug Administration. The Company can now begin commercial distribution of the enhanced WavSTAT technology.
Pearl Therapeutics Inc., a company developing clinically differentiated combination therapies for the treatment of highly prevalent chronic respiratory diseases, today announced positive results from a Phase 1 safety and pharmacokinetics study of PT003, its lead combination therapeutic for the treatment of chronic obstructive pulmonary disease (COPD). Based on these results, and previously announced positive results from Phase 2a studies of PT003's individual components, the company has advanced PT003 into a Phase 2b trial.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the attention-deficit/hyperactivity disorder (ADHD) drug market in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan will fluctuate modestly over the next decade, decreasing from $5 billion in 2009 to a trough in 2013 before climbing to $4.1 billion in 2019.
Abortion-rights groups are holding a lobby day on Wednesday to fight language in the House healthcare bill that would impose greater restrictions on access to the controversial procedure. The amendment by Rep. Bart Stupak (D-Mich.), adopted before House passage on Nov. 21, would prohibit women who receive government subsidies for healthcare from purchasing insurance that covers abortions, and it would prohibit coverage of the procedure in government-run health plans.
› Verified 1 days ago
| Entity Name | Garnet Health Doctors Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093138851 PECOS PAC ID: 8628293545 Enrollment ID: O20140710000189 |
News Archive
SpectraScience, Inc. (OTC Bulletin Board: SCIE), a San Diego based medical device company, today announced that its application for premarket approval (PMA) relating to key enhancements of its WavSTAT platform technology has been approved by the Food and Drug Administration. The Company can now begin commercial distribution of the enhanced WavSTAT technology.
Pearl Therapeutics Inc., a company developing clinically differentiated combination therapies for the treatment of highly prevalent chronic respiratory diseases, today announced positive results from a Phase 1 safety and pharmacokinetics study of PT003, its lead combination therapeutic for the treatment of chronic obstructive pulmonary disease (COPD). Based on these results, and previously announced positive results from Phase 2a studies of PT003's individual components, the company has advanced PT003 into a Phase 2b trial.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the attention-deficit/hyperactivity disorder (ADHD) drug market in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan will fluctuate modestly over the next decade, decreasing from $5 billion in 2009 to a trough in 2013 before climbing to $4.1 billion in 2019.
Abortion-rights groups are holding a lobby day on Wednesday to fight language in the House healthcare bill that would impose greater restrictions on access to the controversial procedure. The amendment by Rep. Bart Stupak (D-Mich.), adopted before House passage on Nov. 21, would prohibit women who receive government subsidies for healthcare from purchasing insurance that covers abortions, and it would prohibit coverage of the procedure in government-run health plans.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miss Stephanie Pulikkottil Joseph, MD 6010 Hidden Valley Rd Ste 200, Carlsbad, CA 92011-4219 Ph: (760) 631-3000 | Miss Stephanie Pulikkottil Joseph, MD 707 E Main St, Middletown, NY 10940-2650 Ph: (845) 333-7575 |
News Archive
SpectraScience, Inc. (OTC Bulletin Board: SCIE), a San Diego based medical device company, today announced that its application for premarket approval (PMA) relating to key enhancements of its WavSTAT platform technology has been approved by the Food and Drug Administration. The Company can now begin commercial distribution of the enhanced WavSTAT technology.
Pearl Therapeutics Inc., a company developing clinically differentiated combination therapies for the treatment of highly prevalent chronic respiratory diseases, today announced positive results from a Phase 1 safety and pharmacokinetics study of PT003, its lead combination therapeutic for the treatment of chronic obstructive pulmonary disease (COPD). Based on these results, and previously announced positive results from Phase 2a studies of PT003's individual components, the company has advanced PT003 into a Phase 2b trial.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the attention-deficit/hyperactivity disorder (ADHD) drug market in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan will fluctuate modestly over the next decade, decreasing from $5 billion in 2009 to a trough in 2013 before climbing to $4.1 billion in 2019.
Abortion-rights groups are holding a lobby day on Wednesday to fight language in the House healthcare bill that would impose greater restrictions on access to the controversial procedure. The amendment by Rep. Bart Stupak (D-Mich.), adopted before House passage on Nov. 21, would prohibit women who receive government subsidies for healthcare from purchasing insurance that covers abortions, and it would prohibit coverage of the procedure in government-run health plans.
› Verified 1 days ago
Nelson Wong, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 60 Dunning Rd, Middletown, NY 10940 Phone: 845-344-4477 Fax: 845-344-6072 | |
Rohit Navlani, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 155 Crystal Run Rd, Middletown, NY 10941 Phone: 845-703-6999 Fax: 845-703-6297 | |
Dr. Thomas John Booker, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 95 Crystal Run Rd, Middletown, NY 10941 Phone: 845-703-6999 Fax: 845-703-6297 | |
Dr. Bindu Pathrose, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 707 E Main St, Middletown, NY 10940 Phone: 845-333-4342 Fax: 845-333-4345 | |
Dr. Yinggang Zheng, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 111 Maltese Dr, Middletown, NY 10940 Phone: 845-342-4774 Fax: 845-343-8741 | |
Dr. Steven Craig Weinstein, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 75 Crystal Run Rd, Suite 206, Middletown, NY 10941 Phone: 845-673-1080 Fax: 845-673-5320 | |
Dr. George Shuxiong Chen, DO Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 707 E Main St, Middletown, NY 10940 Phone: 845-333-7575 |